Phase 2 CMV Clinical Trials
11 recruitingPhase 2
What is a Phase 2 trial?
Phase 2 trials evaluate whether a treatment works for a specific condition and further assess its safety. These studies typically enroll several hundred participants and provide preliminary data on effectiveness.
Showing 1–11 of 11 trials
Recruiting
Phase 2
Trial to Study Anti- HCMV Therapy in Breast Cancer Patients With Progressive Intracranial Metastases and CMV Infection
CMV ViremiaBrain Cancer Metastatic
The Methodist Hospital Research Institute28 enrolled1 locationNCT07383649
Recruiting
Phase 2
CMV CTLs in Neonates With CMV Infection
Congenital Cytomegaloviral (CMV) Disease
New York Medical College23 enrolled4 locationsNCT05564598
Recruiting
Phase 2
Phase II Trial of Maribavir for CMV in Patients With Lymphoid Malignancy on Bispecific Antibodies
Cytomegalovirus (CMV)
Seoul National University Hospital20 enrolled1 locationNCT07014319
Recruiting
Phase 1Phase 2
CMVIG Prophylaxis in Belatacept Conversion Kidney Transplant Recipients
Kidney Transplant; ComplicationsCMV
University of Minnesota30 enrolled1 locationNCT07096453
Recruiting
Phase 2
Study Evaluating the Efficacy and Safety of Artesunate
CMV Infection
Amivas Inc.90 enrolled2 locationsNCT06853184
Recruiting
Phase 2Phase 3
Valganciclovir vs. Letermovir for CMV Prophylaxis in Heart Transplant
Heart Transplant InfectionCMV ViremiaHeart Transplant Failure and Rejection
Columbia University150 enrolled2 locationsNCT07079735
Recruiting
Phase 2
CMV-TCIP Directed Letermovir Prophylaxis After Allo-SCT
allogeneic stem cell transplantationCMV
University of California, Irvine50 enrolled1 locationNCT06453460
Recruiting
Phase 2
Prophylaxis of Cytomegalovirus Infection With Adoptive Cell Inmunotherapy
CMV
Instituto de Investigación Marqués de Valdecilla15 enrolled1 locationNCT04056533
Recruiting
Phase 2
Cytomegalovirus Prophylaxis With Letermovir in Heart Transplant Recipients
CMV Viremia
University Medical Centre Ljubljana90 enrolled1 locationNCT05432778
Recruiting
Phase 2
A randomised trial of third-party virus-specific T cells in patients with untreated viral infection after an allogeneic stem cell transplantation
Cytomegalovirus (CMV) infection
Western Sydney Local Health District144 enrolled6 locationsACTRN12620000171910
Terminated
Phase 2
Adoptive immunotherapy for the prevention of Human Cytomegalovirus (HCMV) reactivation and disease after Allogenic Stem Cell Transplantation
Human Cytomegalovirus (HCMV) reactivation and disease after Allogenic Stem Cell Transplantation
Queensland Institute of Medical Research (QIMR)15 enrolled1 locationACTRN12605000452695